Time to clinical response to secukinumab across disease domains among patients with psoriatic arthritis: a pooled post hoc analysis of the FUTURE 2-5 studies
Time to clinical response to secukinumab across disease domains among patients with psoriatic arthritis: a pooled post hoc analysis of the FUTURE 2-5 studies. // EULAR Rheumatology Open. – URL: https://www.sciencedirect.com/science/article/pii/S305070812600073X?dgcid=rss_sd_all
Time to clinical response to secukinumab across disease domains among patients with psoriatic arthritis: a pooled post hoc analysis of the FUTURE 2-5 studies. EULAR Rheumatology Open. https://www.sciencedirect.com/science/article/pii/S305070812600073X?dgcid=rss_sd_all
“Time to clinical response to secukinumab across disease domains among patients with psoriatic arthritis: a pooled post hoc analysis of the FUTURE 2-5 studies.” EULAR Rheumatology Open.
@article{article116738,
title = {Time to clinical response to secukinumab across disease domains among patients with psoriatic arthritis: a pooled post hoc analysis of the FUTURE 2-5 studies},
journal = {EULAR Rheumatology Open},
url = {https://www.sciencedirect.com/science/article/pii/S305070812600073X?dgcid=rss_sd_all}
}